These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20281096)
1. Subtilin-antibiotic produced by Bacillus subtilis; effect on Streptococcus pyogenes infections in mice. SALLE AJ; JANN GJ Proc Soc Exp Biol Med; 1946 Dec; 63(3):519. PubMed ID: 20281096 [No Abstract] [Full Text] [Related]
2. Subtilin; antibiotic produced by Bacillus subtilis; effect on type III pneumococcus in mice. SALLE AJ; JANN GJ Proc Soc Exp Biol Med; 1946 May; 62():40-2. PubMed ID: 20987562 [No Abstract] [Full Text] [Related]
3. Subtilin, antibiotic produced by Bacillus subtilis; toxicity of subtilin to living embryonic tissue. SALLE AJ; JANN GJ Proc Soc Exp Biol Med; 1946 Jan; 61():23. PubMed ID: 21013787 [No Abstract] [Full Text] [Related]
4. Subtilin, an antibiotic produced by Bacillus subtilis; action on various organisms. SALLE AJ; JANN GJ Proc Soc Exp Biol Med; 1945 Oct; 60():60-4. PubMed ID: 21004031 [No Abstract] [Full Text] [Related]
5. Engineering Bacillus subtilis ATCC 6633 for improved production of the lantibiotic subtilin. Heinzmann S; Entian KD; Stein T Appl Microbiol Biotechnol; 2006 Jan; 69(5):532-6. PubMed ID: 16001258 [TBL] [Abstract][Full Text] [Related]
6. Polypeptide antibiotic 26a from Bacillus subtilis. IV. Evaluation of biological in vivo activity. Jarosz J; Gliński Z Acta Microbiol Pol; 1978; 27(4):375-81. PubMed ID: 86285 [TBL] [Abstract][Full Text] [Related]
7. Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococci. Sanders CC; Sanders WE J Infect Dis; 1982 Nov; 146(5):683-90. PubMed ID: 6752297 [TBL] [Abstract][Full Text] [Related]
8. Sublichenin, a new subtilin-like lantibiotics of probiotic bacterium Bacillus licheniformis MCC 2512 Halami PM Microb Pathog; 2019 Mar; 128():139-146. PubMed ID: 30594640 [TBL] [Abstract][Full Text] [Related]
9. Autoregulation of subtilin biosynthesis in Bacillus subtilis: the role of the spa-box in subtilin-responsive promoters. Kleerebezem M; Bongers R; Rutten G; de Vos WM; Kuipers OP Peptides; 2004 Sep; 25(9):1415-24. PubMed ID: 15374645 [TBL] [Abstract][Full Text] [Related]
10. LanI-Mediated Lantibiotic Immunity in Bacillus subtilis: Functional Analysis. Geiger C; Korn SM; Häsler M; Peetz O; Martin J; Kötter P; Morgner N; Entian KD Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30952662 [TBL] [Abstract][Full Text] [Related]
11. Maturation and processing of SpaI, the lipoprotein involved in subtilin immunity in Bacillus subtilis ATCC 6633. Halami PM; Stein T; Chandrashekar A; Entian KD Microbiol Res; 2010 Mar; 165(3):183-9. PubMed ID: 19540743 [TBL] [Abstract][Full Text] [Related]
13. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Tagg JR Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154 [TBL] [Abstract][Full Text] [Related]
14. The effect of Streptococcus pyogenes extracts and filtrates on various bacteria. NUTINI LG; KELLY TA; McDOWELL MA J Bacteriol; 1947 May; 53(5):575-80. PubMed ID: 20238517 [No Abstract] [Full Text] [Related]
15. THE PHENOMENON OF BACTERIOCINOGENY IN BACILLI OF THE GENUS KLEBSIELLA. I. CHARACTERISTICS OF KLEBSIELLA BACTERIOCINS. DURLAKOWA I; MARESZ BABCZYSZYN J; PRZONDO HESSEK A; LUSAR Z; MROZ KURPIELA E Arch Immunol Ther Exp (Warsz); 1964; 12():308-18. PubMed ID: 14186756 [No Abstract] [Full Text] [Related]
16. A novel post-translational modification of the peptide antibiotic subtilin: isolation and characterization of a natural variant from Bacillus subtilis A.T.C.C. 6633. Chan WC; Bycroft BW; Leyland ML; Lian LY; Roberts GC Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):23-7. PubMed ID: 8471040 [TBL] [Abstract][Full Text] [Related]